Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Change in Accured Expenses (2016 - 2025)

Nephros has reported Change in Accured Expenses over the past 16 years, most recently at $367000.0 for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $367000.0 for Q4 2025, up 50.41% from a year ago — trailing twelve months through Dec 2025 was $1.0 million (up 553.1% YoY), and the annual figure for FY2025 was $1.0 million, up 553.1%.
  • Change in Accured Expenses for Q4 2025 was $367000.0 at Nephros, down from $380000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for NEPH hit a ceiling of $380000.0 in Q3 2025 and a floor of -$380000.0 in Q1 2024.
  • Median Change in Accured Expenses over the past 5 years was $100000.0 (2021), compared with a mean of $71400.0.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 487.76% in 2024 and later surged 663.64% in 2025.
  • Nephros' Change in Accured Expenses stood at -$128000.0 in 2021, then soared by 118.75% to $24000.0 in 2022, then soared by 237.5% to $81000.0 in 2023, then surged by 201.23% to $244000.0 in 2024, then surged by 50.41% to $367000.0 in 2025.
  • The last three reported values for Change in Accured Expenses were $367000.0 (Q4 2025), $380000.0 (Q3 2025), and $168000.0 (Q2 2025) per Business Quant data.